Lingyun Fu
No. 6 Ankang Avenue
Guiyang, 561113, China
Guiyang, 561113, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Mechanistic Insights into Active Components of Rosa Roxburghii Juice Against Fluoride-Induced Osteoarthritis.
Journal: Antioxidants (Basel, Switzerland)
Published: January 04, 2026
Single-cell transcriptomics reveals the ameliorative effect of gastrodin on cholestatic liver fibrosis.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: November 21, 2025
Cyclovirobuxine D ameliorates cardiac hypertrophy by enhancing mitochondrial function via miR-30b-5p/ALCAT1 Pathway.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: August 06, 2025
1,8-Cineole ameliorates vascular endothelial senescence in diabetes mellitus by directly targeting and deubiquitinating PPAR-γ in vivo and in vitro.
Journal: Journal of pharmaceutical analysis
Published: December 17, 2024
Essential oil from Fructus Alpiniae zerumbet ameliorates vascular endothelial cell senescence in diabetes by regulating PPAR-γ signalling: A 4D label-free quantitative proteomics and network pharmacology study.
Journal: Journal of ethnopharmacology
Published: October 28, 2023
Salvianolic acid B ameliorates myocardial fibrosis in diabetic cardiomyopathy by deubiquitinating Smad7.
Journal: Chinese medicine
Published: September 22, 2023
Cyclovirobuxine D alleviates aldosterone-induced myocardial hypertrophy by protecting mitochondrial function depending on the mutual regulation of Nrf2-SIRT3.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 24, 2023
1,8-Cineole ameliorates diabetic retinopathy by inhibiting retinal pigment epithelium ferroptosis via PPAR-γ/TXNIP pathways.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 25, 2023
Cyclovirobuxine D Ameliorates Experimental Diabetic Cardiomyopathy by Inhibiting Cardiomyocyte Pyroptosis via NLRP3 in vivo and in vitro.
Journal: Frontiers in pharmacology
Published: March 28, 2022
Baicalein resensitizes tamoxifen-resistant breast cancer cells by reducing aerobic glycolysis and reversing mitochondrial dysfunction via inhibition of hypoxia-inducible factor-1α.
Journal: Clinical and translational medicine
Published: April 12, 2021
Correction: Baicalein inhibits fibronectin-induced epithelial-mesenchymal transition by decreasing activation and upregulation of calpain-2.
Journal: Cell death & disease
Published: July 15, 2020
Last Updated: 09/26/2026